Rangsima Reantragoon

4.0k total citations · 2 hit papers
34 papers, 2.9k citations indexed

About

Rangsima Reantragoon is a scholar working on Immunology, Rheumatology and Epidemiology. According to data from OpenAlex, Rangsima Reantragoon has authored 34 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 16 papers in Rheumatology and 10 papers in Epidemiology. Recurrent topics in Rangsima Reantragoon's work include Immune Cell Function and Interaction (12 papers), Osteoarthritis Treatment and Mechanisms (10 papers) and T-cell and B-cell Immunology (10 papers). Rangsima Reantragoon is often cited by papers focused on Immune Cell Function and Interaction (12 papers), Osteoarthritis Treatment and Mechanisms (10 papers) and T-cell and B-cell Immunology (10 papers). Rangsima Reantragoon collaborates with scholars based in Thailand, Australia and United Kingdom. Rangsima Reantragoon's co-authors include James McCluskey, Jamie Rossjohn, Onisha Patel, Zhenjun Chen, Lars Kjer‐Nielsen, Bronwyn S. Meehan, Alexandra J. Corbett, David P. Fairlie, Ligong Liu and Lyudmila Kostenko and has published in prestigious journals such as Nature, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Rangsima Reantragoon

33 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MR1 presents microbial vitamin B metabolites to MAIT cells

2012 971 citations Lars Kjer‐Nielsen, Onisha Patel et al. Nature profile →
T-cell activation by transitory neo-antigens derived from distinct microbial pathways

2014 612 citations Alexandra J. Corbett, Sidonia B. G. Eckle et al. Nature profile →

Peers

Countries citing papers authored by Rangsima Reantragoon

Since Specialization

Citations

This map shows the geographic impact of Rangsima Reantragoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rangsima Reantragoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rangsima Reantragoon more than expected).

Fields of papers citing papers by Rangsima Reantragoon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rangsima Reantragoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rangsima Reantragoon. The network helps show where Rangsima Reantragoon may publish in the future.

Co-authorship network of co-authors of Rangsima Reantragoon

This figure shows the co-authorship network connecting the top 25 collaborators of Rangsima Reantragoon. A scholar is included among the top collaborators of Rangsima Reantragoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rangsima Reantragoon. Rangsima Reantragoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Catabolic mediators from TLR2-mediated proteoglycan aggrecan peptide-stimulated chondrocytes are reduced by Lactobacillus-conditioned media 2024 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Srihatach Ngarmukos, Mana Taweevisit, Sutada Lotinun, Somying Tumwasorn, Aree Tanavalee, Rangsima Reantragoon	2
2	Infrapatellar fat pad adipose tissue-derived macrophages display a predominant CD11c+CD206+ phenotype and express genotypes attributable to key features of OA pathogenesis 2024 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), Mana Taweevisit, Srihatach Ngarmukos, (unknown), Tanapat Palaga, Rangsima Reantragoon	6
3	Determination of initial hepatitis B surface antigen (HBsAg) cutoff index (COI) threshold for reporting HBsAg reactivity 2024 ·(unknown), (unknown), Rangsima Reantragoon	0
4	The allopurinol metabolite, oxypurinol, drives oligoclonal expansions of drug‐reactive T cells in resolved hypersensitivity cases and drug‐naïve healthy donors 2023 ·Allergy ·Nicole A. Mifsud, Patricia T. Illing, (unknown), (unknown), Heidi Fettke, (unknown), James McCluskey, Jamie Rossjohn, J.P. Vivian, Rangsima Reantragoon, Anthony W. Purcell	5
5	The Immunological Facets of Chondrocytes in Osteoarthritis: A Narrative Review 2023 ·The Journal of Rheumatology ·(unknown), (unknown), Aree Tanavalee, Rangsima Reantragoon	20
6	TIL expansion with high dose IL-2 or low dose IL-2 with anti-CD3/anti-CD28 stimulation provides different quality of TIL-expanded T cell clones 2022 ·Journal of Immunological Methods ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Koramit Suppipat, Rangsima Reantragoon	9
7	Notch signaling regulates function of human mucosal-associated invariant T (MAIT) cells 2021 ·Asian Pacific Journal of Allergy and Immunology ·Pimpayao Sodsai, (unknown), Nattiya Hirankarn, Rangsima Reantragoon, Tanapat Palaga	1
8	Two or four injections of platelet-rich plasma for osteoarthritic knee did not change synovial biomarkers but similarly improved clinical outcomes 2021 ·Scientific Reports ·Srihatach Ngarmukos, (unknown), (unknown), (unknown), (unknown), Rangsima Reantragoon, (unknown), (unknown), (unknown), Sittisak Honsawek, (unknown), Aree Tanavalee	18
9	Lactobacillus casei l39 as a potential disease-modifying treatment for knee osteoarthritis by reducing intraarticular inflammation 2020 ·Osteoarthritis and Cartilage ·(unknown), (unknown), (unknown), Pongsak Yuktanandana, Srihatach Ngarmukos, Aree Tanavalee, Rangsima Reantragoon	2
10	Successful direct-acting antiviral therapy improves circulating mucosal-associated invariant T cells in patients with chronic HCV infection 2020 ·PLoS ONE ·(unknown), Natthaya Chuaypen, Pimpayao Sodsai, Rangsima Reantragoon, Win Min Han, Anchalee Avihingsanon, Pisit Tangkijvanich	8
11	Down-regulation of miR-155 after treatment with narrow-band UVB and methotrexate associates with apoptosis of keratinocytes in psoriasis 2019 ·Asian Pacific Journal of Allergy and Immunology ·Wipasiri Soonthornchai, Pattarin Tangtanatakul, Jitlada Meephansan, Kriangsak Ruchusatsawat, Rangsima Reantragoon, Nattiya Hirankarn, Jongkonnee Wongpiyabovorn	18
12	Monitoring Anti-Pythium insidiosum IgG Antibodies and (1→3)-β- d -Glucan in Vascular Pythiosis 2018 ·Journal of Clinical Microbiology ·Navaporn Worasilchai, Nitipong Permpalung, Pakawat Chongsathidkiet, Asada Leelahavanichkul, (unknown), Tanapat Palaga, Rangsima Reantragoon, Malcolm Finkelman, Pranee Sutcharitchan, Ariya Chindamporn	16
13	T Cells and Osteoarthritis 2017 ·Osteoarthritis and Cartilage ·(unknown), (unknown), Srihatach Ngarmukos, Pongsak Yuktanandana, Aree Tanavalee, Rangsima Reantragoon	2
14	Transcriptomic profiling in human mesangial cells using patient-derived lupus autoantibodies identified miR-10a as a potential regulator of IL8 2017 ·Scientific Reports ·Pattarin Tangtanatakul, (unknown), Alain Jacquet, Rangsima Reantragoon, Trairak Pisitkun, Yingyos Avihingsanon, Asada Leelahavanichkul, Nattiya Hirankarn	23
15	T-cell activation by transitory neo-antigens derived from distinct microbial pathways breakdown → 2014 ·Nature ·Alexandra J. Corbett, Sidonia B. G. Eckle, Richard W. Birkinshaw, Ligong Liu, Onisha Patel, Jennifer Mahony, Zhenjun Chen, Rangsima Reantragoon, Bronwyn S. Meehan, Hanwei Cao, Nicholas A. Williamson, Richard A. Strugnell, Douwe van Sinderen, Jeffrey Y. W. Mak, David P. Fairlie, Lars Kjer‐Nielsen, Jamie Rossjohn, James McCluskey	612
16	A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells 2014 ·The Journal of Experimental Medicine ·Sidonia B. G. Eckle, Richard W. Birkinshaw, Lyudmila Kostenko, Alexandra J. Corbett, Hamish E. G. McWilliam, Rangsima Reantragoon, Zhenjun Chen, Nicholas A. Gherardin, Travis Beddoe, Ligong Liu, Onisha Patel, Bronwyn S. Meehan, David P. Fairlie, Jóse A. Villadangos, Dale I. Godfrey, Lars Kjer‐Nielsen, James McCluskey, Jamie Rossjohn	226
17	Recognition of vitamin B metabolites by mucosal-associated invariant T cells 2013 ·Nature Communications ·Onisha Patel, Lars Kjer‐Nielsen, Jérôme Le Nours, Sidonia B. G. Eckle, Richard W. Birkinshaw, Travis Beddoe, Alexandra J. Corbett, Ligong Liu, John J. Miles, Bronwyn S. Meehan, Rangsima Reantragoon, Maria L. Sandoval-Romero, Lucy C. Sullivan, Andrëw G. Brööks, Zhenjun Chen, David P. Fairlie, James McCluskey, Jamie Rossjohn	238
18	MR1 presents microbial vitamin B metabolites to MAIT cells breakdown → 2012 ·Nature ·Lars Kjer‐Nielsen, Onisha Patel, Alexandra J. Corbett, Jérôme Le Nours, Bronwyn S. Meehan, Ligong Liu, Mugdha Bhati, Zhenjun Chen, Lyudmila Kostenko, Rangsima Reantragoon, Nicholas A. Williamson, Anthony W. Purcell, Nadine L. Dudek, Malcolm J. McConville, Richard A. J. O’Hair, George N. Khairallah, Dale I. Godfrey, David P. Fairlie, Jamie Rossjohn, James McCluskey	971
19	Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor 2012 ·The Journal of Experimental Medicine ·Rangsima Reantragoon, Lars Kjer‐Nielsen, Onisha Patel, Zhenjun Chen, Patricia T. Illing, Mugdha Bhati, Lyudmila Kostenko, Mandvi Bharadwaj, Bronwyn S. Meehan, Ted H. Hansen, Dale I. Godfrey, Jamie Rossjohn, James McCluskey	147
20	Asthma Research Performance in Asia-Pacific: A Bibliometric Analysis by Searching PubMed Database 2009 ·Journal of Asthma ·Jettanong Klaewsongkram, Rangsima Reantragoon	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact